...
首页> 外文期刊>Science >Interleukin-13: central mediator of allergic asthma (see comments)
【24h】

Interleukin-13: central mediator of allergic asthma (see comments)

机译:白细胞介素13:过敏性哮喘的主要介质(见评论)

获取原文
获取原文并翻译 | 示例
           

摘要

The worldwide incidence, morbidity, and mortality of allergic asthma are increasing. The pathophysiological features of allergic asthma are thought to result from the aberrant expansion of CD4(+) T cells producing the type 2 cytokines interleukin-4 (IL-4) and IL-5, although a necessary role for these cytokines in allergic asthma has not been demonstrable. The type 2 cytokine IL-13, which shares a receptor component and signaling pathways with IL-4, was found to be necessary and sufficient for the expression of allergic asthma. IL-13 induces the pathophysiological features of asthma in a manner that is independent of immunoglobulin E and eosinophils. Thus, IL-13 is critical to allergen-induced asthma but operates through mechanisms other than those that are classically implicated in allergic responses.
机译:过敏性哮喘的全球发病率,发病率和死亡率正在增加。过敏性哮喘的病理生理特征被认为是由产生2型细胞因子白介素4(IL-4)和IL-5的CD4(+)T细胞异常扩增导致的,尽管这些细胞因子在过敏性哮喘中的必要作用是没有被证明。发现与IL-4共享受体成分和信号传导途径的2型细胞因子IL-13对于表达过敏性哮喘是必要和充分的。 IL-13以独立于免疫球蛋白E和嗜酸性粒细胞的方式诱导哮喘的病理生理特征。因此,IL-13对过敏原诱发的哮喘至关重要,但其作用机制不同于传统上与过敏反应有关的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号